Ranajit Kumar Mondal

461 total citations
15 papers, 334 citations indexed

About

Ranajit Kumar Mondal is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Ranajit Kumar Mondal has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Cancer Research. Recurrent topics in Ranajit Kumar Mondal's work include Epigenetics and DNA Methylation (7 papers), Cervical Cancer and HPV Research (6 papers) and Cancer-related gene regulation (5 papers). Ranajit Kumar Mondal is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cervical Cancer and HPV Research (6 papers) and Cancer-related gene regulation (5 papers). Ranajit Kumar Mondal collaborates with scholars based in India, United States and Australia. Ranajit Kumar Mondal's co-authors include Chinmay Kumar Panda, Partha Basu, Anup Roy, Susanta Roychoudhury, Ratnesh Singh, Sankhadeep Dutta, Anirban Roychowdhury, Sankar Addya, Susanta Roychowdhury and Pijush K. Das and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Ranajit Kumar Mondal

15 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranajit Kumar Mondal India 11 234 119 119 55 44 15 334
Yuanhang Zhu China 12 155 0.7× 86 0.7× 114 1.0× 39 0.7× 31 0.7× 20 264
Ola Elazazy Egypt 11 272 1.2× 41 0.3× 292 2.5× 53 1.0× 48 1.1× 18 416
Reem K. Shahin Egypt 11 291 1.2× 44 0.4× 310 2.6× 57 1.0× 55 1.3× 14 412
Svenja Adrian Germany 7 128 0.5× 40 0.3× 39 0.3× 103 1.9× 24 0.5× 14 270
Akao Zhu China 9 217 0.9× 40 0.3× 178 1.5× 37 0.7× 23 0.5× 20 294
N Echeverry Switzerland 6 259 1.1× 60 0.5× 76 0.6× 39 0.7× 7 0.2× 6 347
Chandni Patel United States 8 98 0.4× 66 0.6× 24 0.2× 41 0.7× 20 0.5× 15 188
Jun Nie China 11 105 0.4× 58 0.5× 69 0.6× 266 4.8× 23 0.5× 31 392
Lucia Torres Fernández Germany 7 213 0.9× 46 0.4× 96 0.8× 48 0.9× 18 0.4× 8 311

Countries citing papers authored by Ranajit Kumar Mondal

Since Specialization
Citations

This map shows the geographic impact of Ranajit Kumar Mondal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranajit Kumar Mondal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranajit Kumar Mondal more than expected).

Fields of papers citing papers by Ranajit Kumar Mondal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranajit Kumar Mondal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranajit Kumar Mondal. The network helps show where Ranajit Kumar Mondal may publish in the future.

Co-authorship network of co-authors of Ranajit Kumar Mondal

This figure shows the co-authorship network connecting the top 25 collaborators of Ranajit Kumar Mondal. A scholar is included among the top collaborators of Ranajit Kumar Mondal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranajit Kumar Mondal. Ranajit Kumar Mondal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Roychowdhury, Anirban, Debolina Pal, Ranajit Kumar Mondal, et al.. (2023). Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma. Cellular Signalling. 109. 110735–110735. 2 indexed citations
2.
Roychowdhury, Anirban, Debolina Pal, Ranajit Kumar Mondal, et al.. (2022). PTPRJ is downregulated in cervical squamous cell carcinoma. Journal of Genetics. 101(2). 3 indexed citations
3.
Roychowdhury, Anirban, Pijush K. Das, A Chatterjee, et al.. (2019). Deregulation of H19 is associated with cervical carcinoma. Genomics. 112(1). 961–970. 48 indexed citations
4.
Roychowdhury, Anirban, Pijush K. Das, Ranajit Kumar Mondal, et al.. (2019). IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients. Biochemical Genetics. 57(5). 638–651. 3 indexed citations
5.
Islam, S. M. Ashiqul, Anirban Roychowdhury, Pijush K. Das, et al.. (2017). Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates. Virus Research. 243. 1–9. 4 indexed citations
6.
Roychowdhury, Anirban, Pijush K. Das, Sankar Addya, et al.. (2016). Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(1). 2899–2911. 10 indexed citations
7.
Dutta, Sankhadeep, Nupur Mukherjee, Anirban Roychowdhury, et al.. (2014). Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication. Tumor Biology. 36(2). 1143–1154. 20 indexed citations
8.
Dutta, Sankhadeep, Ranajit Kumar Mondal, Jaydip Biswas, et al.. (2012). Prevalence of Human Papillomavirus in Women Without Cervical Cancer. International Journal of Gynecological Pathology. 31(2). 178–183. 34 indexed citations
9.
Mondal, Ranajit Kumar, et al.. (2012). Inactivation of SLIT2-ROBO1/2 Pathway in Premalignant Lesions of Uterine Cervix: Clinical and Prognostic Significances. PLoS ONE. 7(6). e38342–e38342. 26 indexed citations
10.
Singh, Ratnesh, Sankhadeep Dutta, Partha Basu, et al.. (2011). Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Gynecologic Oncology. 123(3). 597–604. 54 indexed citations
11.
Basu, Partha, et al.. (2011). Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance. Molecular Carcinogenesis. 51(9). 723–733. 14 indexed citations
12.
Basu, Partha, et al.. (2010). Amplification of CyclinL1 in uterine cervical carcinoma has prognostic implications. Molecular Carcinogenesis. 49(11). 935–943. 11 indexed citations
13.
Singh, Ratnesh, Sankhadeep Dutta, Anup Roy, et al.. (2010). Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: Clinical and prognostic implications. International Journal of Cancer. 129(8). 1859–1871. 26 indexed citations
14.
Singh, Ratnesh, Partha Basu, Ranajit Kumar Mondal, et al.. (2009). RBSP3 is frequently altered in premalignant cervical lesions: Clinical and prognostic significance. Genes Chromosomes and Cancer. 49(2). 155–170. 28 indexed citations
15.
Singh, Ratnesh, Ranajit Kumar Mondal, Partha Basu, et al.. (2007). Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Human Genetics. 122(1). 71–81. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026